FY2025 · ended Dec 31, 2025 · Revenue $295.30M, +5.9% YoY · Filed Feb 27, 2026
Inogen, Inc. (INGN) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $295.3 million and a net loss of $22.7 million. Free cash flow was -$13.7 million. As of Jun 30, 2026 it held $105.5 million in cash and investments and $15.8 million in total debt.
Revenue (TTM)
$303.59M
+5.1% vs year-ago TTM
Net income (TTM)
$-24.59M
+5.6% vs year-ago TTM
Operating cash flow (TTM)
$-2.52M
+70.3% vs year-ago TTM
Free cash flow (TTM)
$-4.98M
+56.4% vs year-ago TTM
EPS (TTM)
$-0.91
+13.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
27.23M
+2.6% vs prior year
Net cash
$89.75M
as of Jun 30, 2026
Operating margin
-10.2%
FY 2026
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- INGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Beverly, MA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1294133
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $295.3M | $278.8M | $251.6M | $320.5M | $311.7M |
| Operating income | -$30.2M | -$42.5M | -$109.4M | -$85.2M | $9.2M |
| Net income | -$22.7M | -$35.9M | -$102.4M | -$83.8M | -$6.3M |
| Diluted EPS | -$0.86 | -$1.52 | -$4.42 | -$3.67 | -$0.28 |
| Operating cash flow | -$11.2M | $5.9M | -$3.2M | -$37.5M | $23.6M |
| Free cash flow | -$13.7M | $2.6M | -$8.5M | -$40.9M | $18.2M |
| Total assets | $298.6M | $296.2M | $326.2M | $405.0M | $489.5M |
| Total liabilities | $106.4M | $122.3M | $121.4M | $107.6M | $119.3M |
| Stockholders' equity | $192.2M | $173.9M | $204.8M | $297.4M | $370.2M |
| Cash and investments | $119.6M | $113.8M | $128.5M | $187.0M | $245.5M |
| Total debt | $17.5M | $19.4M | $21.9M | $23.3M | $26.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 28, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2026 | Jun 5, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
All 1000 Inogen, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.